EA014641B1 - Сукцинатная и малонатная соли транс-4-((1r,3s )-6 хлор-3-фенилиндан -1-ил)-1,2,2-триметилпиперазина и их применение в качестве лекарственного средства - Google Patents
Сукцинатная и малонатная соли транс-4-((1r,3s )-6 хлор-3-фенилиндан -1-ил)-1,2,2-триметилпиперазина и их применение в качестве лекарственного средства Download PDFInfo
- Publication number
- EA014641B1 EA014641B1 EA200600441A EA200600441A EA014641B1 EA 014641 B1 EA014641 B1 EA 014641B1 EA 200600441 A EA200600441 A EA 200600441A EA 200600441 A EA200600441 A EA 200600441A EA 014641 B1 EA014641 B1 EA 014641B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compound
- salt
- formula
- schizophrenia
- disorder
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
- C07C25/18—Polycyclic aromatic halogenated hydrocarbons
- C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
- C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
- C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200301180 | 2003-08-18 | ||
DKPA200301305 | 2003-09-11 | ||
PCT/DK2004/000545 WO2005016900A1 (en) | 2003-08-18 | 2004-08-18 | Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200600441A1 EA200600441A1 (ru) | 2006-08-25 |
EA014641B1 true EA014641B1 (ru) | 2010-12-30 |
Family
ID=58707237
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200600441A EA014641B1 (ru) | 2003-08-18 | 2004-08-18 | Сукцинатная и малонатная соли транс-4-((1r,3s )-6 хлор-3-фенилиндан -1-ил)-1,2,2-триметилпиперазина и их применение в качестве лекарственного средства |
EA200600443A EA200600443A1 (ru) | 2003-08-18 | 2004-08-18 | Транс-1-(6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазин |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200600443A EA200600443A1 (ru) | 2003-08-18 | 2004-08-18 | Транс-1-(6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазин |
Country Status (16)
Country | Link |
---|---|
KR (2) | KR101227789B1 (es) |
CN (1) | CN101935305B (es) |
AR (2) | AR045278A1 (es) |
AT (1) | ATE552247T1 (es) |
DK (1) | DK1658277T3 (es) |
EA (2) | EA014641B1 (es) |
ES (1) | ES2383369T3 (es) |
HK (2) | HK1096089A1 (es) |
IS (1) | IS8264A (es) |
ME (1) | MEP2408A (es) |
MY (2) | MY154535A (es) |
PT (1) | PT1658277E (es) |
RS (3) | RS20060121A (es) |
SG (2) | SG145723A1 (es) |
SI (1) | SI1658277T1 (es) |
TW (2) | TWI403505B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI453198B (zh) * | 2005-02-16 | 2014-09-21 | Lundbeck & Co As H | 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s)-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法 |
JP5668177B2 (ja) | 2011-06-20 | 2015-02-12 | ハー・ルンドベック・アクチエゼルスカベット | 統合失調症の治療のための重水素化1−ピペラジノ−3−フェニルインダン |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0638073B1 (en) * | 1992-04-28 | 2000-06-21 | H. Lundbeck A/S | 1-piperazino-1,2-dihydroindene derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE50867B1 (en) * | 1980-02-29 | 1986-08-06 | Kefalas As | Indane derivatives |
-
2004
- 2004-08-18 AR ARP040102966A patent/AR045278A1/es not_active Application Discontinuation
- 2004-08-18 SI SI200431885T patent/SI1658277T1/sl unknown
- 2004-08-18 EA EA200600441A patent/EA014641B1/ru not_active IP Right Cessation
- 2004-08-18 RS YUP-2006/0121A patent/RS20060121A/sr unknown
- 2004-08-18 SG SG200805893-5A patent/SG145723A1/en unknown
- 2004-08-18 RS RS20060121A patent/RS53369B/en unknown
- 2004-08-18 CN CN2010101632528A patent/CN101935305B/zh not_active Expired - Fee Related
- 2004-08-18 RS YUP-2006/0083A patent/RS20060083A/sr unknown
- 2004-08-18 SG SG200808521-9A patent/SG148183A1/en unknown
- 2004-08-18 PT PT04762772T patent/PT1658277E/pt unknown
- 2004-08-18 TW TW099140932A patent/TWI403505B/zh not_active IP Right Cessation
- 2004-08-18 DK DK04762772.4T patent/DK1658277T3/da active
- 2004-08-18 EA EA200600443A patent/EA200600443A1/ru unknown
- 2004-08-18 KR KR1020067003177A patent/KR101227789B1/ko active IP Right Grant
- 2004-08-18 MY MYPI20082882A patent/MY154535A/en unknown
- 2004-08-18 AT AT04762772T patent/ATE552247T1/de active
- 2004-08-18 KR KR1020067003357A patent/KR20060066104A/ko not_active Application Discontinuation
- 2004-08-18 AR ARP040102967A patent/AR045279A1/es not_active Application Discontinuation
- 2004-08-18 TW TW093124784A patent/TWI388550B/zh not_active IP Right Cessation
- 2004-08-18 MY MYPI20043353A patent/MY149089A/en unknown
- 2004-08-18 ME MEP-24/08A patent/MEP2408A/xx unknown
- 2004-08-18 ES ES04762772T patent/ES2383369T3/es not_active Expired - Lifetime
-
2006
- 2006-01-26 IS IS8264A patent/IS8264A/is unknown
-
2007
- 2007-03-21 HK HK07103032.7A patent/HK1096089A1/xx not_active IP Right Cessation
-
2011
- 2011-06-29 HK HK11106689.0A patent/HK1152699A1/xx not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0638073B1 (en) * | 1992-04-28 | 2000-06-21 | H. Lundbeck A/S | 1-piperazino-1,2-dihydroindene derivatives |
Non-Patent Citations (2)
Title |
---|
KLAUS P. BOGOSO ET AL.: "Enhanced D1 Affinity in a Series of Piperazine Ring Substituted 1-Piperazi- no-3-Arylindanes with Potential Atypical Antipsychotic Activity", JOURNAL OF MEDICINAL CHEMISTRY., vol. 38, no. 22, 1995, pages 4380-4392, XP008037648 * |
USAMERICAN CHEMICAL SOCIETY. WASHINGTON, cited in the application, page 4383, scheme 1; page 4383, compound (-)-38; page 4386, table 5, compound (-)-38, page 4387, table 6, compound (-)-38 * |
Also Published As
Publication number | Publication date |
---|---|
RS20060121A (en) | 2008-09-29 |
TW201111351A (en) | 2011-04-01 |
MY149089A (en) | 2013-07-15 |
RS53369B (en) | 2014-10-31 |
SI1658277T1 (sl) | 2012-10-30 |
EA200600443A1 (ru) | 2006-08-25 |
HK1096089A1 (en) | 2007-05-25 |
EA200600441A1 (ru) | 2006-08-25 |
KR20060066104A (ko) | 2006-06-15 |
CN101935305B (zh) | 2013-04-10 |
SG148183A1 (en) | 2008-12-31 |
CN101935305A (zh) | 2011-01-05 |
TW200519098A (en) | 2005-06-16 |
DK1658277T3 (da) | 2012-06-18 |
RS20060083A (en) | 2008-08-07 |
ES2383369T3 (es) | 2012-06-20 |
KR101227789B1 (ko) | 2013-01-30 |
ATE552247T1 (de) | 2012-04-15 |
MEP2408A (xx) | 2010-02-10 |
TWI388550B (zh) | 2013-03-11 |
TWI403505B (zh) | 2013-08-01 |
IS8264A (is) | 2006-01-26 |
AR045279A1 (es) | 2005-10-19 |
HK1152699A1 (en) | 2012-03-09 |
MY154535A (en) | 2015-06-30 |
KR20060066094A (ko) | 2006-06-15 |
AR045278A1 (es) | 2005-10-19 |
SG145723A1 (en) | 2008-09-29 |
PT1658277E (pt) | 2012-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5553802B2 (ja) | トランス−4−((1r,3s)−6−クロロ−3−フェニルインダン−1−イル)−1,2,2−トリメチルピペラジンのコハク酸塩およびマロン酸塩、および薬剤としての使用方法 | |
KR20070103386A (ko) | 트랜스-1-((1r,3s)-6-클로로-3-페닐인단-1-일)-3,3-디메틸피페라진의 제조 방법 | |
JP2008530039A (ja) | トランス−1−((1r,3s)−6−クロロ−3−フェニルインダン−1−イル)−3,3−ジメチルピペラジンの酒石酸塩およびリンゴ酸塩 | |
US20100105699A1 (en) | Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine | |
EA014641B1 (ru) | Сукцинатная и малонатная соли транс-4-((1r,3s )-6 хлор-3-фенилиндан -1-ил)-1,2,2-триметилпиперазина и их применение в качестве лекарственного средства | |
JP4165882B2 (ja) | 治療用化合物のクエン酸塩及びその医薬組成物 | |
SK10222001A3 (sk) | Morfolinobenzamidové soli | |
CN1839124B (zh) | 反式-4-((1r,3s)-6-氯-3-苯基茚满-1-基)-1,2,2-三甲基哌嗪的琥珀酸盐和丙二酸盐,及其作为药物的用途 | |
KR20070107043A (ko) | 트랜스-1-((1r,3s)-6-클로로-3-페닐인단-1-일)-3,3-디메틸피페라진의 타르트레이트 및 말레이트 염 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): BY RU |